Animal model Aβ42 Olfaction Pharmaco-fUS Amyloid-β plaques Agonist Drug discovery Synucleinopathies Central nervous system Amyloid‐β Radiotracer Magnetic resonance imaging Biomarker Alzheimer diagnosis Sniffing Blood biomarker Amyloid-beta peptides 18 FF13640 Locus coeruleus Amyotrophic lateral sclerosis Recent memory Piriform cortex Agonists Amyloid-beta Striatum Inflammation 11Cyohimbine Biomarkers neuroinflammation positron emission tomography Cerebrospinal fluid 18FFDG PET imaging Proteinopathies 14-3-3 protein Remote memory System-level consolidation Adverse events Autoradiography Dementia 18FFDG micro PET Fibril aggregates Agonistes Alert system 5-HT1A Autoimmune encephalitis Creutzfeldt-Jakob disease 5-HT6 receptor Atomoxetine 5-HT1A receptors 3D virtual histopathology Alzheimer’s disease Positron emission tomography Parkinson's disease Biomarqueurs Non-human primate A-BETA Alzheimer's disease Alpha-synuclein Power law exponent Analytical confounders TEP Multiple system atrophy Frontotemporal lobar degeneration 18F-florbetapir Neurodegenerative diseases Stroke Noradrenaline Acute ischemic stroke Bayesian inference Multiple sclerosis Neuroinflammation Biased agonism Atmospheric pollution PET/MRI Attention-deficit hyperactivity disorder Anxiety behavior Aβ40 Alzheimer Animal models Accident vasculaire cérébral 5-HT 6 receptor Α2-adrenergic receptors MicroPET 11CPF-3274167 Amyloid Serotonin PET Biomarkers Brain Anti-CD20 18FFluorodeoxyglucose Neuroimaging 5-HT 1A receptors Binding Magnetic resonance elastography BIOMARKAPD 5-Ht1A and 5-HT6 receptors Middle cerebral artery occlusion Neuropharmacology Automation